TASK DEFINITION: Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
PROBLEM: Paragraph: The significant costs of both drugs were mentioned. Nice job. Good job describing the benefits reported in the two drug studies. The two papers present a bewildering array of statistics. This story did a nice job distilling the information into a couple of very understandable sentences. Good job explaining signifcant potential harms of both drugs something competitors didn't do at all. Nice job, including linking (in the online version) to the papers in the New England Journal of Medicine. No disease-mongering of melanoma. Several independent sources cited. The story adequately explained the comparisons between both new drugs and the older dacarbazine chemo drug. Vemurafenib was described as experimental and as "expected to be approved by the FDA within a few months." Ipilimumab was explained to be approved in March and already on the market. The relative novelty of both drugs was well explained. It's clear that the story did not rely on a news release. Claim: Drugs Show Promise Slowing Advanced Melanoma

SOLUTION: The story made strong, clear attempts to report in a restrained manner, using terms/phrases such as: "notable progress" "do not cure" "might add two to several moths to expected lifespans" "To be sure, more than half of patients with metastatic melanoma would not be helped all that much by either drug." Stories about cancer perhaps especially melanoma because of its treatment challenges should balance promise with realistic context. This story did a better job of that than the competitors' efforts we reviewed.

PROBLEM: Paragraph: A developmental biologist and tissue engineer, Dr. Mironov, 56, is one of only a few scientists worldwide involved in bioengineering "cultured" meat. It's a product he believes could help solve future global food crises resulting from shrinking amounts of land available for growing meat the old-fashioned way ... on the hoof. Growth of "in-vitro" or cultured meat is also under way in the Netherlands, Mironov told Reuters in an interview, but in the United States, it is science in search of funding and demand. The new National Institute of Food and Agriculture, part of the U.S. Food and Drug Administration, won't fund it, the National Institutes of Health won't fund it, and the National Aeronautics and Space Administration funded it only briefly, Mironov said. "It's classic disruptive technology," Mironov said. "Bringing any new technology on the market, average, costs $1 billion. We don't even have $1 million." Director of the Advanced Tissue Biofabrication Center in the Department of Regenerative Medicine and Cell Biology at the medical university, Mironov now primarily conducts research on tissue engineering, or growing, of human organs. "There's a yuck factor when people find out meat is grown in a lab. They don't like to associate technology with food," said Nicholas Genovese, 32, a visiting scholar in cancer cell biology working under a People for the Ethical Treatment of Animals three-year grant to run Dr. Mironov's meat-growing lab. "But there are a lot of products that we eat today that are considered natural that are produced in a similar manner," Genovese said. "There's yogurt, which is cultured yeast. You have wine production and beer production. These were not produced in laboratories. Society has accepted these products." If wine is produced in winery, beer in a brewery and bread in a bakery, where are you going to grow cultured meat? In a "carnery," if Mironov has his way. That is the name he has given future production facilities. He envisions football field-sized buildings filled with large bioreactors, or bioreactors the size of a coffee machine in grocery stores, to manufacture what he calls "charlem" "Charleston engineered meat." "It will be functional, natural, designed food," Mironov said. "How do you want it to taste? You want a little bit of fat, you want pork, you want lamb? We design exactly what you want. We can design texture. "I believe we can do it without genes. But there is no evidence that if you add genes the quality of food will somehow suffer. Genetically modified food is already normal practice and nobody dies." Dr. Mironov has taken myoblasts embryonic cells that develop into muscle tissue from turkey and bathed them in a nutrient bath of bovine serum on a scaffold made of chitosan (a common polymer found in nature) to grow animal skeletal muscle tissue. But how do you get that juicy, meaty quality? Genovese said scientists want to add fat. And adding a vascular system so that interior cells can receive oxygen will enable the growth of steak, say, instead of just thin strips of muscle tissue. Cultured meat could eventually become cheaper than what Genovese called the heavily subsidized production of farm meat, he said, and if the public accepts cultured meat, the future holds benefits. "Thirty percent of the earth's land surface area is associated with producing animal protein on farms," Genovese said. "Animals require between 3 and 8 pounds of nutrient to make 1 pound of meat. It's fairly inefficient. Animals consume food and produce waste. Cultured meat doesn't have a digestive system. "Further out, if we have interplanetary exploration, people will need to produce food in space and you can't take a cow with you. "We have to look to these ideas in order to progress. Otherwise, we stay static. I mean, 15 years ago who could have imagined the iPhone?" Claim: South Carolina scientist works to grow meat in lab.

SOLUTION: In a small laboratory on an upper floor of the basic science building at the Medical University of South Carolina, Vladimir Mironov, M.D., Ph.D., has been working for a decade to grow meat.

PROBLEM: Paragraph: Jose Miguel Cisneros, director of the infectious disease department at Seville's Virgen del Rocio Hospital, on Tuesday announced the first casualty since the outbreak was declared on Aug. 15. Authorities have closed the pork meat supplier's plant and recalled all of its products. Cisneros said roughly half of the 114 people affected by the bacteria remain hospitalized. Health Minister Maria Luisa Carcedo said an investigation is looking into how the meat evaded what she called "strict food safety controls." Listeria is a bacteria that usually causes mild illness in healthy people but can be dangerous to pregnant women and those with weakened immune systems. Claim: Woman dies in Spain as listeria-in-pork outbreak sickens 114.

SOLUTION:
Health authorities in Spain are on high alert after a 90-year-old woman died amid a listeria outbreak in the southern region of Andalusia that has affected more than 110 people.